A message from RxFunction regarding COVID-19.
In The News
RxFunction Announces Leadership Change
RxFunction Awarded Department of Defense Contract for Project
RxFunction Presents at Two Virtual Scientific Neurology Conferences
RxFunction Adds VP of Business Development
Johns Hopkins School of Medicine, Baltimore, Maryland added as 5th walk2Wellness Clinical Study Site
Lars Oddsson Presents March 6th at ISPRM 2020
walk2Wellness Clinical Data Presented at ACRM 2019
RxFunction Expands IP with Patent Issued August 2019
Hebrew SeniorLife Added to walk2Wellness Clinical Trial
Walkasins® clinical research published April 30, 2019 in PLOS ONE. Shows short-term use of device lowers fall-risk for peripheral neuropathy patients.
Next Page »
© 2020 RxFunction, Inc.